Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Provention Bio, Inc. (PRVB)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 | Sep-30-20 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | | | | |
| Cost of goods sold | 0.0% | 0.0% | 0.0% | 0.0% | | | | |
| Gross profit | 100.0% | 100.0% | 100.0% | 100.0% | | | | |
| Research and development | 2458.8% | 3407.3% | 4991.2% | 11056.0% | | | | |
| General and administrative | 1751.9% | 2373.2% | 3394.0% | 7087.9% | | | | |
| EBITDA | -4092.1% | -5657.7% | -8257.4% | -18002.2% | | | | |
| Depreciation | 18.6% | 22.8% | 27.7% | 41.7% | | | | |
| EBIT | -4110.7% | -5680.6% | -8285.2% | -18044.0% | | | | |
| Pre-tax income | -4100.0% | -5671.7% | -8274.7% | -18020.6% | | | | |
| Income taxes | -259.3% | -407.9% | -71.7% | -147.5% | | | | |
| Net income | -3840.7% | -5263.8% | -8203.0% | -17873.2% | | | | |
|